Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary M Hitt

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Molecular Therapy Oncolytics|November 30, 2023
Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachmentFrancisca Cristi, Maiah Walters, Nashae Narayan, et al.
Biomedical Optics Express|April 13, 2011
Tyrosinase as a dual reporter gene for both photoacoustic and magnetic resonance imagingRobert J Paproski, Alexander E Forbrich, Keith Wachowicz, et al.
Plos One|January 7, 2014
Myxoma virus oncolytic efficiency can be enhanced through chemical or genetic disruption of the actin cytoskeletonChad R Irwin, Nicole A Favis, Kate C Agopsowicz, et al.
Plos One|June 11, 2013
2-aminopurine enhances the oncolytic activity of an E1b-deleted adenovirus in hepatocellular carcinoma cellsDavid Sharon, Michael Schümann, Sheena MacLeod, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
Comparative functional evaluation of immunocompetent mouse breast cancer models established from PyMT-tumors using small animal PET with [(18)F]FDG and [(18)F]FLTAlan Desilva, Melinda Wuest, Monica Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cellsChang-Xin Shi, Michael A Long, Limin Liu, et al.
Cancer Letters|November 28, 2021
Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinomaClayton J Bell, Kyle G Potts, Mary M Hitt, et al.
Journal of Virology|August 30, 2019
Breast Tumor-Associated Metalloproteases Restrict Reovirus Oncolysis by Cleaving the σ1 Cell Attachment Protein and Can Be Overcome by Mutation of σ1Jason P Fernandes, Francisca Cristi, Heather E Eaton, et al.
Pediatric Research|May 22, 2020
Incomplete resection of necrotic bowel may increase mortality in infants with necrotizing enterocolitisParvesh Mohan Garg, Anas Bernieh, Mary M Hitt, et al.
Scientific Reports|June 4, 2021
Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transitionElizabeth Garcia, Ismat Luna, Kaya L Persad, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Molecular Therapy Oncolytics|November 30, 2023
Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachmentFrancisca Cristi, Maiah Walters, Nashae Narayan, et al.
Biomedical Optics Express|April 13, 2011
Tyrosinase as a dual reporter gene for both photoacoustic and magnetic resonance imagingRobert J Paproski, Alexander E Forbrich, Keith Wachowicz, et al.
Plos One|January 7, 2014
Myxoma virus oncolytic efficiency can be enhanced through chemical or genetic disruption of the actin cytoskeletonChad R Irwin, Nicole A Favis, Kate C Agopsowicz, et al.
Plos One|June 11, 2013
2-aminopurine enhances the oncolytic activity of an E1b-deleted adenovirus in hepatocellular carcinoma cellsDavid Sharon, Michael Schümann, Sheena MacLeod, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
Comparative functional evaluation of immunocompetent mouse breast cancer models established from PyMT-tumors using small animal PET with [(18)F]FDG and [(18)F]FLTAlan Desilva, Melinda Wuest, Monica Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cellsChang-Xin Shi, Michael A Long, Limin Liu, et al.
Cancer Letters|November 28, 2021
Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinomaClayton J Bell, Kyle G Potts, Mary M Hitt, et al.
Journal of Virology|August 30, 2019
Breast Tumor-Associated Metalloproteases Restrict Reovirus Oncolysis by Cleaving the σ1 Cell Attachment Protein and Can Be Overcome by Mutation of σ1Jason P Fernandes, Francisca Cristi, Heather E Eaton, et al.
Pediatric Research|May 22, 2020
Incomplete resection of necrotic bowel may increase mortality in infants with necrotizing enterocolitisParvesh Mohan Garg, Anas Bernieh, Mary M Hitt, et al.
Scientific Reports|June 4, 2021
Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transitionElizabeth Garcia, Ismat Luna, Kaya L Persad, et al.
Pageof 3